Conventionally, DNA based investigations for fetal diseases are done by chorionic villous sampling and amniocentesis. Both are invasive techniques. Recently, molecular diagnosis has also been made possible in early pregnancy from maternal blood which is noninvasive and advantageous. Most of the researches have tried to identify the Y chromosome marker(s) to detect a male fetus and paternally inherited allele. This is currently helpful to detect a very few genetic disorders including Rh D status in Rh negative women in early pregnancy and preeclampsia a few weeks preceding the clinical onset. This is a potential area for prenatal diagnosis in future
The discovery of cell-free fetal DNA in maternal serum and plasma has opened a new avenue for noninv...
Prenatal diagnosis of genetic disorders has traditionally relied on invasive procedures such as amni...
BACKGROUND: Invasive procedures to obtain fetal DNA for prenatal blood grouping present a risk to th...
Conventionally, DNA based investigations for fetal diseases are done by chorionic villous sampling ...
Since the presence of large amounts of circulating fetal DNA in maternal plasma and serum samples wa...
suggests that different targets should be equally effective for quantification of the total DNA in t...
Prenatal diagnosis for genetic diseases nowadays is still carried out by invasive procedures such as...
OBJECTIVE: Our objective was to examine whether plasma fetal DNA can be used as a screening variable...
Non-invasive prenatal diagnosis (NIPD) is based on fetal DNA analysis starting from a simple periphe...
We have developed a real-time quantitative PCR assay to measure the concentration of fetal DNA in ma...
Although the first finding that fetal cells can enter the maternal circulation was made more than a ...
SummaryWe have developed a real-time quantitative PCR assay to measure the concentration of fetal DN...
The discovery of circulating cell-free fetal DNA in maternal plasma/serum, in 1997, and the demonstr...
WOS: 000399349900004Hemoglobin disorders such as thalassemias and sickle cell anemias can be avoided...
Advances in molecular genetics have allowed the investigation of the foetal genome through analysis ...
The discovery of cell-free fetal DNA in maternal serum and plasma has opened a new avenue for noninv...
Prenatal diagnosis of genetic disorders has traditionally relied on invasive procedures such as amni...
BACKGROUND: Invasive procedures to obtain fetal DNA for prenatal blood grouping present a risk to th...
Conventionally, DNA based investigations for fetal diseases are done by chorionic villous sampling ...
Since the presence of large amounts of circulating fetal DNA in maternal plasma and serum samples wa...
suggests that different targets should be equally effective for quantification of the total DNA in t...
Prenatal diagnosis for genetic diseases nowadays is still carried out by invasive procedures such as...
OBJECTIVE: Our objective was to examine whether plasma fetal DNA can be used as a screening variable...
Non-invasive prenatal diagnosis (NIPD) is based on fetal DNA analysis starting from a simple periphe...
We have developed a real-time quantitative PCR assay to measure the concentration of fetal DNA in ma...
Although the first finding that fetal cells can enter the maternal circulation was made more than a ...
SummaryWe have developed a real-time quantitative PCR assay to measure the concentration of fetal DN...
The discovery of circulating cell-free fetal DNA in maternal plasma/serum, in 1997, and the demonstr...
WOS: 000399349900004Hemoglobin disorders such as thalassemias and sickle cell anemias can be avoided...
Advances in molecular genetics have allowed the investigation of the foetal genome through analysis ...
The discovery of cell-free fetal DNA in maternal serum and plasma has opened a new avenue for noninv...
Prenatal diagnosis of genetic disorders has traditionally relied on invasive procedures such as amni...
BACKGROUND: Invasive procedures to obtain fetal DNA for prenatal blood grouping present a risk to th...